*Not all patients are eligible to use the Co-pay savings card. Certain restrictions apply.
You should discuss the potential benefits and risks of HADLIMA with your doctor. HADLIMA is a tumor necrosis factor (TNF) blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HADLIMA if you have any kind of infection unless your doctor says it is okay.
Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HADLIMA, and check you closely for signs and symptoms of TB during treatment with HADLIMA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
Cancer. For children and adults taking TNF blockers, including HADLIMA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers, including HADLIMA, your chance of getting 2 types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life threatening if treated; tell your doctor if you have a bump or open sore that does not heal.
Also tell your doctor about all the medicines you take. You should not take HADLIMA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
Call your doctor or get medical care right away if you develop any of the above symptoms.
Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:
HADLIMA is given by injection under the skin.
This is the most important information to know about HADLIMA. For more information, talk to your health care provider.
Please read the Medication Guide for HADLIMA, including the information about serious infections and cancers, and discuss it with your doctor. The Instructions for Use and Physician Prescribing Information also are available.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.